Abstract
Adipose tissue is an important source of angiotensinogen (AGT). Recent evidence shows that a local renin–angiotensinogen system (RAS) is present in human adipose tissue and may act as a distinct system from plasma RAS. In obese patients, the involvement of angiotensin II (angII) as a consequence of increased plasma AGT secreted from adipose tissue has been proposed in the development of hypertension. Another role of AGT via angII in the development of adipose tissue is supported by the following: (i) in vitro, angII stimulates the production and release of prostacyclin from adipocytes, which in turn promotes the differentiation of precursor cells into adipocytes; (ii) ex vivo and in vivo, both angII and (carba)prostacyclin promote the formation of new fat cells; and (iii) AGT−/−mice exhibit a slowing down of adipose tissue development, as compared to wild-type mice. Altogether the data are consistent with an autocrine/paracrine mechanism implicating AGT, angII and prostacyclin in adipose tissue development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ailhaud, G., Fukamizu, A., Massiera, F. et al. Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes 24 (Suppl 4), S33–S35 (2000). https://doi.org/10.1038/sj.ijo.0801501
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801501
Keywords
This article is cited by
-
Adipocyte–progenitor cell communication that influences adipogenesis
Cellular and Molecular Life Sciences (2020)
-
Changes of Percent Body Fat as a Useful Surrogate for Risk of Declined Renal Function
Scientific Reports (2018)
-
Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment
Diabetology & Metabolic Syndrome (2010)
-
Knockdown of angiotensinogen by shRNA-mediated RNA interference inhibits human visceral preadipocytes differentiation
International Journal of Obesity (2010)
-
The value of current interventions for obesity
Nature Clinical Practice Cardiovascular Medicine (2008)